- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with multiple myeloma (MM). - In South Korea, XPOVIO® has been approved for three indications across MM and diffuse large B-cell lymphoma (DLBCL), and two of these approved indications have been included in the national reimbursement scheme. SHANGHAI and HONG KONG, March 2, 2026 -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech c
[ 메디채널 김갑성 기자 ] SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today announced positive topline results from its Phase III clinical trial evaluating zemprocitinib in patients with moderate-to-severe atopic dermatitis (AD). The study met all co-primary and key secondary endpoints, with both dose groups demonstrating highly and statistically significant improvements versus placebo (p < 0.0001), together wi
SAN FRANCISCO and SUZHOU, China, March 2, 2026 -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic, and other major diseases, announces the non-covalent (reversible) Bruton's tyrosine kinase (BTK) inhibitor, Jaypirca® (pirtobrutinib), has received approval by the National Medical Products Administration (NMPA) in China for a new indication for the treatment of adult patients wit
The Future of Prostate Imaging: What do physicians want? MELBOURNE, Australia and INDIANAPOLIS, March 2, 2026 -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") invites investors to join a webinar with key opinion leaders to discuss a physician's perspective on innovations in PSMA-PET/CT imaging for prostate cancer. Speakers: Rodney Hicks, MD, Professor of Medicine at the University of Melbourne and Monash University; Founder, Executive Chairman and Chief Medical Officer at the Melbourne Theranostic Innovation Centre (MTIC
[ 메디채널 황정호 기자 ] 뉘른베르크, 독일 2026년 3월 1일 -- 적외선 열화상 이미징 분야의 선도 기업인 가이드(Guide)가 IWA 아웃도어클래식 2026(IWA OutdoorClassics 2026)에서 성공적으로 쇼케이스를 마무리하며 글로벌 사냥 및 야외용품 업계에 깊은 인상을 남겼다. 이번 행사는 ApexVision 기술과 클립온 플래그십 모델 TU1260MS의 공식 데뷔 무대로, 수천 명의 방문객이 4A-511 부스를 방문해 차세대 열화상 성능을 직접 확인했다. 현장 체험 성과: ApexVision 심층 공개 행사의 하이라이트는 풍부한 현장 경험을 보유한 독일 베테랑 사냥꾼 안드레아스 트렌칭어(Andreas Trenzinger)씨가 진행한 Deep Dive 세션이었다. 안드레아스 트렌칭어씨는 IWA 현장에서 실시간으로 촬영한 TU1260MS 영상과 신제품 사전 테스트 영상을 공유하며 ApexVision의 우수성을 입증했다. 참석자들은 칠흑같이 어두운 극한의 환경에서도 최적의 디테일을 유지하고, 배경과 목표물을 명확히 구분하며, 높은 동적 범위를 구현하는 혁신 기술을 직접 목격했다. 안드레아스 트렌
NÜRNBERG, Germany, March 1, 2026 -- Guide, a leader in infrared thermal imaging, concluded its highly successful showcase at IWA OutdoorClassics 2026, leaving a lasting impression on the global hunting and outdoor industry. The event served as the official debut for ApexVision technology, and the clip-on flagship TU1260MS, drawing thousands of attendees to Booth 4A-511 for a first-hand look at the future of thermal performance. Hands-On Success: The ApexVision Deep Dive The highlight of the event was the exclusive Deep Dive led by Andreas Trenzinger, a seasoned Germ
SYDNEY, March 1, 2026 -- Wellkins Capital Limited, a specialist private credit and real estate investment manager, is pleased to announce a new $4.6 million secured mezzanine note issuance by Bella Rosanna Capital Pty Ltd. The funds raised will support the development of a 27-townhouse residential project located in Rosanna, Victoria. The project is positioned within Melbourne's established northern residential corridor and is intended for sale upon completion. The secured mezzanine notes offer a targeted return of 16% per annum (IRR) over a term of up to 24 months. The investme
BARCELONA, Spain, March 1, 2026 -- Innovative AI-driven brand TECNO is set to unveil a suite of cutting-edge innovations at MWC 2026 in Barcelona, headlined by the debut of its latest flagship imaging and AI smartphone family, the CAMON 50 Series, together with its AI Product Ecosystem and official announcement of its strategic partnership with Tonino Lamborghini. TECNO CAMON 50 Series: Reshaping Mobile Imaging with Upgraded AI Power With the CAMON 50 Series, TECNO advances its mobile photography by syncing flagship Sony hardware with a dedicated AI computing architectur
[ 메디채널 김장윤(JASON KIM) 기자 ] 北京、2026年3月1日 -- 2月24日、ジュネーブのパレ・デ・ナシオンで30点を超える精巧な徳化白磁作品が披露され、中国の伝統工芸の現代的な活力を示しました。 伝統的な美意識と現代的なデザインを融合した展示品は、国連職員、ジュネーブの外交官、中国とスイスの代表者を引き付け、中国の陶磁文化ならではの魅力を示しました。 中国南東部・福建省の徳化県は、グローバルガバナンスと高品質な企業発展に関するシンポジウムの期間中、「Blanc de Chine • Porcelain from Dehua」のプロモーションイベントを開催し、文化遺産を世界的な発展と調和させるとともに、質の高い産業成長を推進する取り組みを示しました。 一方、「Blanc de Chine • Porcelain from Dehua」のプロモーションセンターも開設されました。徳化県のFang Junqin党委書記は、このセンターの開設は、徳化の陶磁器が欧州市場へさらに進出するための重要な一歩になると述べました。 陶磁器産業クラスターの規模は760億元を超え、製品は190を超える国・地域に輸出されており、徳化は重要な生産・イノベーション拠点へと成長しています。同県は、AI支援設計や3Dプ
BARCELONA, Spain, March 1, 2026 -- RayNeo, a leading innovator in augmented reality (AR) wearable technology, today unveiled the Batman Edition of its latest smart glasses, the RayNeo Air 4 Pro, at MWC 2026. Available for purchase since February 27, 2026, RayNeo Air 4 Pro comes in both a Standard Edition and Batman Editions, offering consumers more personalized choices that blend practical entertainment and productivity with everyday cosplay expression. Next-Generation Entertainment: The RayNeo Air 4 Pro Positioned as a "new species of head-mounted TV,"